Tanabe Pharma Corporation: all 185 studies

Page 1 of 2. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Study of BK1803 in Healthy InfantsNot yet recruitingNCT07793513Phase 3
• A Study of MT-4561 in Patients With Various Advanced Solid TumorsRecruitingNCT06943521Phase 1/2
• Safety of Argatroban Infusion in Conduction DisturbancesCompletedNCT05740371Phase 4Results posted
• Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）TerminatedNCT05065619Phase 1/2Results posted
• Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and OlderCompletedNCT04622592Phase 1/2Results posted
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic SclerosisCompletedNCT04440592Phase 2Results posted
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked ProtoporphyriaCompletedNCT04402489Phase 3Results posted
• Confirmatory Study of BK1310 in Healthy InfantsCompletedNCT03891758Phase 3Results posted
• Safety and Efficacy Study of MT-2990 in Women With EndometriosisCompletedNCT03840993Phase 2Results posted
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy SubjectsTerminatedNCT03809039Phase 1Results posted
• Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the ElderlyCompletedNCT03739112Phase 3Results posted
• Effects of Iron Supplements on the Pharmacokinetics of MT-6548CompletedNCT03645863Phase 3Results posted
• Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor SymptomsCompletedNCT03541200Phase 2Results posted
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic ProtoporphyriaCompletedNCT03520036Phase 2Results posted
• Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in JapanCompletedNCT03461146Phase 3Results posted
• Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in JapanCompletedNCT03439137Phase 3Results posted
• Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic NephropathyCompletedNCT03436693Phase 3Results posted
• Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in JapanCompletedNCT03402386Phase 3Results posted
• Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in JapanCompletedNCT03329196Phase 3Results posted
• Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy AdultsCompletedNCT03321968Phase 3Results posted
• Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in AdultsCompletedNCT03301051Phase 3Results posted
• MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal WomenCompletedNCT03291067Phase 2Results posted
• Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe PainCompletedNCT03245008Phase 2/3Results posted
• Safety and Efficacy of BK1310 Intramuscular Injection in Healthy InfantsCompletedNCT03188692Phase 3Results posted
• Efficacy and Safety of MT-5199 in Subjects With Tardive DyskinesiaCompletedNCT03176771Phase 2/3Results posted
• Phase 3 Study of BK1310 in Healthy InfantsCompletedNCT02992925Phase 3Results posted
• Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes MellitusCompletedNCT02924064Phase 3Results posted
• Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes MellitusCompletedNCT02916706Phase 3Results posted
• A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's DiseaseActive, not recruitingNCT02726386Phase 2Results posted
• Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT02622113Phase 4Results posted
• A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's DiseaseCompletedNCT02577523Phase 2Results posted
• Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)CompletedNCT02354235Phase 3Results posted
• Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)CompletedNCT02354222Phase 3Results posted
• Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic PatientsCompletedNCT02314637Phase 3Results posted
• Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes MellitusCompletedNCT02227849Phase 4Results posted
• Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT02220920Phase 4Results posted
• Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 DiabetesCompletedNCT02220907Phase 3Results posted
• Exploratory Clinical Study of MT-2301CompletedNCT02140047Phase 2Results posted
• Study of BK1301 (DTaP Vaccine) as a Booster in AdolescentsCompletedNCT02118961Phase 3Results posted
• Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT02081599Phase 4Results posted
• Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy SubjectsCompletedNCT01976572Phase 1Results posted
• A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedNCT01900054Phase 3Results posted
• A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease PatientsCompletedNCT01883505Phase 2Results posted
• The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedNCT01861522Phase 3Results posted
• A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic DermatitisCompletedNCT01840605Phase 3Results posted
• Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)CompletedNCT01753570Phase 3Results posted
• Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis CCompletedNCT01753557Phase 3Results posted
• A Clinical Study of Increased Dose of TA-650 in Patients With PsoriasisCompletedNCT01680159Phase 3Results posted
• A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs SchizophreniaCompletedNCT01626885Phase 2/3Results posted
• Long-Term Study of MP-214 in Patients With SchizophreniaCompletedNCT01626872Phase 2/3Results posted
• A Pharmacokinetic Study of MP-214 in Patients With SchizophreniaCompletedNCT01626859Phase 2/3Results posted
• A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly SchizophreniaCompletedNCT01625897Phase 2/3Results posted
• Safety and Efficacy of MP-214 in Patients With SchizophreniaCompletedNCT01625000Phase 2/3Results posted
• Clinical Study of TA-650 in Patients With Refractory Kawasaki DiseaseCompletedNCT01596335Phase 3Results posted
• Clinical Study of TA-650 in Pediatric Patients With Ulcerative ColitisCompletedNCT01585155Phase 3Results posted
• Clinical Study of TA-650 in Pediatric Patients With Crohn's DiseaseCompletedNCT01580670Phase 3Results posted
• Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special LesionsCompletedNCT01532570Phase 3Results posted
• A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal ImpairmentCompletedNCT01512849Phase 1Results posted
• Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected PatientsCompletedNCT01468584Phase 3Results posted
• Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected PatientsCompletedNCT01466192Phase 3Results posted
• A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic RhinitisCompletedNCT01425632Phase 3Results posted
• Efficacy and Safety Study of TA-7284 in Patients With Type 2 DiabetesCompletedNCT01413204Phase 3Results posted
• Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes MellitusCompletedNCT01387737Phase 3Results posted
• Long-term Safety Study of MP-513 in Patients With Type 2 DiabetesCompletedNCT01301833Phase 3Results posted
• Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid ArthritisCompletedNCT01143337Phase 2Results posted
• Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes MellitusCompletedNCT01072331Phase 3Results posted
• Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 DiabetesCompletedNCT01026194Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 DiabetesCompletedNCT01022112Phase 2Results posted
• Monotherapy Study of MP-513 in Patients With Type 2 DiabetesCompletedNCT00998881Phase 3Results posted
• Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 DiabetesCompletedNCT00974090Phase 3Results posted
• Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00971243Phase 2Results posted
• Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With SchizophreniaCompletedNCT00862992Phase 2Results posted
• Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type IICompletedNCT00861692Phase 2Results posted
• Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on DialysisCompletedNCT00858637Phase 3Results posted
• Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)CompletedNCT00805766Phase 3Results posted
• Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based TherapyCompletedNCT00781274Phase 3Results posted
• Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based TherapyCompletedNCT00780910Phase 3Results posted
• Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis CCompletedNCT00780416Phase 3Results posted
• Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedNCT00772382Phase 3Results posted
• Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic PatientsCompletedNCT00707954Phase 1/2Results posted
• Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid ArthritisCompletedNCT00691028Phase 3Results posted
• A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis CCompletedNCT00630058Phase 1Results posted
• Efficacy and Safety Study of MP-513 in Patients With Type 2 DiabetesCompletedNCT00628212Phase 2Results posted
• Safety and Efficacy of MP-424 to Treat Chronic Hepatitis CCompletedNCT00621296Phase 2Results posted
• Safety and PK Study of MP-424 to Treat Chronic Hepatitis CCompletedNCT00591214Phase 1Results posted
• A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedNCT00542815Phase 3Results posted
• A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and DyslipidaemiaCompletedNCT00542386Phase 3Results posted
• Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)CompletedNCT00508924Phase 2Results posted
• A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With HyperphosphatemiaCompletedNCT00506441Phase 3Results posted
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)CompletedNCT00501046Phase 3Results posted
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)CompletedNCT00500682Phase 3Results posted
• Efficacy and Safety Study of MCI-196 in Patients With Type 2 DiabetesCompletedNCT00497198Phase 2Results posted
• A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With HyperphosphatemiaCompletedNCT00416520Phase 3Results posted
• Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）CompletedNCT00412867Phase 4Results posted
• Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis CCompletedNCT00200343Phase 3Results posted
• Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic StrokeCompletedNCT00147316Phase 3Results posted
• The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.CompletedNCT06994286Phase 1
• Clinical Pharmacology Study of MT-3534 in Healthy Adult Male VolunteersCompletedNCT06482346Phase 1
• An Exploratory Study of MT-2990 in Patients With AAVCompletedNCT06196905Phase 1
• INcreased Sun Exposure Without Pain In Research Participants With EPP or XLPCompletedNCT06144840Phase 3

← Tanabe Pharma Corporation overview and focus areas